Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15266412 | 0.90 | — | — | |
| SCHEMBL15266623 | 0.90 | — | — | |
| SCHEMBL15266830 | 0.88 | — | — | |
| SCHEMBL251739 | 0.83 | ACHE (0.33) | ALDH1A1TSHRMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL15266415 | 0.82 | — | — | |
| SCHEMBL15266655 | 0.81 | — | — | |
| SCHEMBL15302361 | 0.80 | MEN1 (0.32) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL17886484 | 0.79 | — | — | |
| SCHEMBL6401841 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TSHRSMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL18145378 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2287231-B1 | Ulltraviolet transmissive polyhedral silsesquioxane polymers | PANASONIC CORP (JP) | 2012-06-06 | — | — | EP | claimed |
| US-20110251357-A1 | ULTRAVIOLET TRANSMISSIVE POLYHEDRAL SILSESQUIOXANE POLYMERS | PANASONIC ELECTRIC WORKS CO., LTD. | 2011-10-13 | — | — | US | claimed |
| EP-2287231-A2 | Ulltraviolet transmissive polyhedral silesquioxane polymers | Panasonic Electric Works Co., Ltd. (JP) | 2011-02-23 | — | — | EP | claimed |
| US-20060122351-A1 | Ultraviolet transmissive polyhedral silsesquioxane polymers | PANASONIC ELECTRIC WORKS CO., LTD. (JP) | 2006-06-08 | — | — | US | claimed |
| US-11807758-B2 | Siloxane polymer and method of producing siloxane polymer | JNC CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-9458177-B2 | Oxazolidin-2-one compounds and uses thereof | NOVARTIS AG (CH) | 2016-10-04 | — | — | US | disclosed |
| EP-2817307-B1 | OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF AS PI3KS INHIBITORS | NOVARTIS AG (CH) | 2016-07-13 | — | — | EP | disclosed |
| US-20150344735-A1 | Curable Silicone Composition, Cured Product Thereof, And Optical Semiconductor Device | DOW CORNING TORAY CO., LTD. (JP) | 2015-12-03 | — | — | US | disclosed |
| US-20140378450-A1 | OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2014-12-25 | — | — | US | disclosed |
| US-8865894-B2 | Oxazolidin-2-one compounds and uses thereof | NOVARTIS AG (CH) | 2014-10-21 | — | — | US | disclosed |
| US-20130225574-A1 | OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2013-08-29 | — | — | US | disclosed |
| EP-2287231-B1 | Ulltraviolet transmissive polyhedral silsesquioxane polymers | PANASONIC CORP (JP) | 2012-06-06 | — | — | EP | disclosed |
| US-20110251357-A1 | ULTRAVIOLET TRANSMISSIVE POLYHEDRAL SILSESQUIOXANE POLYMERS | PANASONIC ELECTRIC WORKS CO., LTD. | 2011-10-13 | — | — | US | disclosed |
| US-7915369-B2 | Ultraviolet transmissive polyhedral silsesquioxane polymers | PANASONIC ELECTRIC WORKS CO., LTD. (JP) | 2011-03-29 | — | — | US | disclosed |
| EP-2287231-A2 | Ulltraviolet transmissive polyhedral silesquioxane polymers | Panasonic Electric Works Co., Ltd. (JP) | 2011-02-23 | — | — | EP | disclosed |
| US-20060122351-A1 | Ultraviolet transmissive polyhedral silsesquioxane polymers | PANASONIC ELECTRIC WORKS CO., LTD. (JP) | 2006-06-08 | — | — | US | disclosed |
| US-6156429-A | POLYLACTONES; DEGRADABLE NON-TOXIC PRODUCTS USED FOR EXAMPLE FOR PACKAGING (FILMS) OR IN MEDICINE (IMPLANTS) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2000-12-05 | — | — | US | disclosed |
| US-5321150-A | 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids | ELI LILLY AND COMPANY (US) | 1994-06-14 | — | — | US | disclosed |
| EP-0552552-A2 | 5-Deazafolic acid derivatives and their use as antineoplastics agents | ELI LILLY AND COMPANY (US) | 1993-07-28 | — | — | EP | disclosed |
| US-5159079-A | 2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids | ELI LILLY AND COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378450-A1 | OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF | PIK3CA, PIK3CD, PIK3CB | ALDH1A1 2637/4885TSHR 3875/4885KDM4E 3476/4885 |
| US-20130225574-A1 | OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF | PIK3CA, PIK3CD, PIK3CB | ALDH1A1 2637/4885TSHR 3875/4885KDM4E 3476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.